David Zidar, MD

Showing    of 4 results

Clinical Trial at UH Seeks to Improve Outcomes for TAVR Patients

Two anti-platelet drugs studied for their effect on platelet function and immune activation post-procedure Innovations in Cardiovascular Medicine & Surgery - Fall 2018  David A. Zidar, MD, PhD Transcatheter aortic valve replacement (TAVR) has...

Statins Under-Prescribed in the Young with Severe Dyslipidemia

Harrington Heart & Vascular Institute Innovations - Winter 2017 - View Full PDF   David A. Zidar, MD, PHD A major driver of heart disease is high cholesterol, especially elevated levels of low-density lipoprotein (LDL) or “bad” cholesterol. Among...

Making the Case for CT CORONARY CALCIUM SCORING

Innovative, no-cost program increases access to vital test Harrington Heart & Vascular Institute Innovations - Spring 2016, updated January 2017 David A. Zidar, MD, PHD Robert C Gilkeson, MD Preventive cardiologists continue to refine their risk...

Asking Questions Giving Options

New clinical trials open for advanced LV heart failure, chelation therapy and renal denervation for treatment-resistant hypertension Guilherme Oliveira, MD Sahil Parikh, MD David Zidar, MD, PHD Harrington Heart & Vascular Institute Innovations...

Results are loading...
Back to Top